Full name
INNGEN LABORATORIUM BADAŃ GENETYCZNYCH SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
86.90.E - Healthcare
63.1 - Services related to computing infrastructure, data processing, website management (hosting), and related activities
72.11.Z - Scientific research and development activities
72.19.Z - Scientific research and development activities
85.59.B - Courses and training for acquiring knowledge, skills, and professional qualifications in non-school forms
86.22.Z - Specialist medical practice
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 0 | -0,3 | 0,1 | 127,8 |
EBITDA | 0,1 | -0,2 | 0,2 | 200,9 |
Short time liabilities | 0,2 | 0,6 | 1,5 | 147,8 |
Equity capital | 0,4 | 0,1 | 0,2 | 123,1 |
Operating profit (EBIT) | 0 | -0,3 | 0,1 | 122,6 |
Assets | 0,6 | 0,8 | 1,7 | 126,3 |
Net profit (loss) | 0 | -0,3 | 0,1 | 127,8 |
Cash | 0 | 0 | 0 | 165,8 |
Liabilities and provisions for liabilities | 0,2 | 0,7 | 1,5 | 126,7 |
Net income from sale | 1 | 1,6 | 2,5 | 60 |
Working assets | 0,5 | 0,3 | 1,2 | 353,2 |
Depreciation | 0,1 | 0,1 | 0,1 | -3,5 |
% | % | % | p.p. | |
Profitability of capital | 0,5 | -474 | 59,1 | 533,1 |
Equity capital to total assets | 66,5 | 9,2 | 9,1 | -0,1 |
Gross profit margin | 0,2 | -20,7 | 3,6 | 24,3 |
EBITDA Margin | 6 | -12,1 | 7,6 | 19,7 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 59 | 141 | 219 | 78 |
Current financial liquidity indicator | 2.774721384048462 | 0.4375232756137848 | 0.8002586960792542 | 0,4 |
Net dept to EBITDA | 1.4842153787612915 | -0.9644514322280884 | 4.714226245880127 | 5,7 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane